Literature DB >> 6296906

The effects of morphine and delta-9-tetrahydrocannabinol on motor activity in rats.

F C Tulunay, I H Ayhan, S B Sparber.   

Abstract

Acute treatment of rats either by high doses of morphine or delta 9-tetrahydrocannabinol (THC) decreased locomotor activity. Naloxone reversed morphine-induced depression completely and reversed THC-induced depression only partially. On day 3 of treatment, tolerance developed to the locomotor inhibitory action of THC or morphine and partial cross-tolerance was observed to the depressant action of THC. Naloxone slightly depressed locomotor activity in THC-tolerant rats, but increased motor activity in morphine-tolerant rats.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6296906     DOI: 10.1007/bf00433741

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.

Authors:  B Hine; E Friedman; M Torrelio; S Gershon
Journal:  Science       Date:  1975-02-07       Impact factor: 47.728

2.  Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.

Authors:  P F Anderson; D M Jackson; G B Chesher; R Malor
Journal:  Psychopharmacologia       Date:  1975-07-23

3.  Naloxone-induced or postwithdrawal abstinence signs in delta9-tetrahydrocannabinol-tolerant rats.

Authors:  S Kaymakçalan; I H Ayhan; F C Tulunay
Journal:  Psychopharmacology (Berl)       Date:  1977-12-28       Impact factor: 4.530

4.  Behavioral effects of separate and combined administration of naloxone and d-amphetamine.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

Review 5.  Interactions of active constituents of marihuana with other drugs in the neuron.

Authors:  W L Dewey; K M Johnson; A S Bloom
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

6.  Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.

Authors:  B Hine; M Torrelio; S Gershon
Journal:  Psychopharmacol Commun       Date:  1975

7.  Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats.

Authors:  R D Sofia; H B Vassar; L C Knobloch
Journal:  Psychopharmacologia       Date:  1975

8.  1-delta9-tetrahydrocannabinol: neurochemical and behavioral effects in the mouse.

Authors:  D Holtzman; R A Lovell; J H Jaffe; D X Freedman
Journal:  Science       Date:  1969-03-28       Impact factor: 47.728

9.  Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats.

Authors:  F C Tulunay; I H Ayhan; P S Portoghese; A E Takemori
Journal:  Eur J Pharmacol       Date:  1981-03-12       Impact factor: 4.432

10.  A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats.

Authors:  V F Gellert; S B Sparber
Journal:  J Pharmacol Exp Ther       Date:  1977-04       Impact factor: 4.030

View more
  4 in total

1.  Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat.

Authors:  E A Stein; S A Fuller; W S Edgemond; W B Campbell
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  A genetic reduction in the serotonin transporter differentially influences MDMA and heroin induced behaviours.

Authors:  Bridget W Brox; Bart A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  2018-03-21       Impact factor: 4.530

Review 3.  Signal transduction via cannabinoid receptors.

Authors:  George D Dalton; Caroline E Bass; C G Van Horn; Allyn C Howlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

Review 4.  Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.

Authors:  Andrew J Kesner; David M Lovinger
Journal:  J Neurochem       Date:  2021-05-16       Impact factor: 5.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.